company background image
HSKA logo

Heska NasdaqCM:HSKA Stock Report

Last Price

US$119.99

Market Cap

US$1.3b

7D

0.1%

1Y

39.9%

Updated

14 Jun, 2023

Data

Company Financials +

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

HSKA Stock Overview

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia.

HSKA fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Heska Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Heska
Historical stock prices
Current Share PriceUS$119.99
52 Week HighUS$120.03
52 Week LowUS$57.83
Beta1.58
1 Month Change2.58%
3 Month Change33.75%
1 Year Change39.93%
3 Year Change34.49%
5 Year Change13.65%
Change since IPO39.12%

Recent News & Updates

Recent updates

Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

Feb 09
Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 50%?

Jan 18
Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 50%?

Heska to acquire LightDeck Diagnostics for $38.7M

Sep 12

Is Heska (NASDAQ:HSKA) A Risky Investment?

Sep 07
Is Heska (NASDAQ:HSKA) A Risky Investment?

Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 31%?

Aug 17
Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 31%?

Heska Non-GAAP EPS of $0.34 misses by $0.03, revenue of $64.7M misses by $3.76M

Aug 08

Is Heska (NASDAQ:HSKA) A Risky Investment?

May 09
Is Heska (NASDAQ:HSKA) A Risky Investment?

Heska Corporation (NASDAQ:HSKA) Shares Could Be 50% Below Their Intrinsic Value Estimate

Apr 03
Heska Corporation (NASDAQ:HSKA) Shares Could Be 50% Below Their Intrinsic Value Estimate

What Is Heska Corporation's (NASDAQ:HSKA) Share Price Doing?

Mar 02
What Is Heska Corporation's (NASDAQ:HSKA) Share Price Doing?

Heska (NASDAQ:HSKA) Has A Rock Solid Balance Sheet

Jan 09
Heska (NASDAQ:HSKA) Has A Rock Solid Balance Sheet

Estimating The Fair Value Of Heska Corporation (NASDAQ:HSKA)

Dec 13
Estimating The Fair Value Of Heska Corporation (NASDAQ:HSKA)

What Does Heska Corporation's (NASDAQ:HSKA) Share Price Indicate?

Nov 17
What Does Heska Corporation's (NASDAQ:HSKA) Share Price Indicate?

Is Heska (NASDAQ:HSKA) A Risky Investment?

Sep 28
Is Heska (NASDAQ:HSKA) A Risky Investment?

Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

Jul 21
Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

Is Heska (NASDAQ:HSKA) A Risky Investment?

Jun 29
Is Heska (NASDAQ:HSKA) A Risky Investment?

Calculating The Intrinsic Value Of Heska Corporation (NASDAQ:HSKA)

May 28
Calculating The Intrinsic Value Of Heska Corporation (NASDAQ:HSKA)

Heska EPS beats by $0.69, beats on revenue

May 06

Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

Apr 15
Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

How Much Are Heska Corporation (NASDAQ:HSKA) Insiders Taking Off The Table?

Mar 19
How Much Are Heska Corporation (NASDAQ:HSKA) Insiders Taking Off The Table?

A Look At The Fair Value Of Heska Corporation (NASDAQ:HSKA)

Feb 21
A Look At The Fair Value Of Heska Corporation (NASDAQ:HSKA)

Shareholder Returns

HSKAUS Medical EquipmentUS Market
7D0.1%1.8%1.2%
1Y39.9%-0.5%24.9%

Return vs Industry: HSKA exceeded the US Medical Equipment industry which returned 16.3% over the past year.

Return vs Market: HSKA exceeded the US Market which returned 15.1% over the past year.

Price Volatility

Is HSKA's price volatile compared to industry and market?
HSKA volatility
HSKA Average Weekly Movement6.3%
Medical Equipment Industry Average Movement7.2%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: HSKA's share price has been volatile over the past 3 months.

Volatility Over Time: HSKA's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988808Kevin Wilsonwww.heska.com

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops.

Heska Corporation Fundamentals Summary

How do Heska's earnings and revenue compare to its market cap?
HSKA fundamental statistics
Market capUS$1.31b
Earnings (TTM)-US$20.03m
Revenue (TTM)US$254.89m

5.1x

P/S Ratio

-65.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HSKA income statement (TTM)
RevenueUS$254.89m
Cost of RevenueUS$145.47m
Gross ProfitUS$109.42m
Other ExpensesUS$129.45m
Earnings-US$20.03m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.84
Gross Margin42.93%
Net Profit Margin-7.86%
Debt/Equity Ratio22.9%

How did HSKA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.